MDL Sought For Vena Cava IVC Filters
The Judicial Panel on Multidistrict Litigation (JPML) heard oral arguments last week in the consideration of approval for a centralized MDL for the Bard inferior vena cava (IVC) filter lawsuits. These claims are mounting up against C.R. Bard. Cook Medical, has already been centralized.
The IVC filters are surgically implanted in patients who are at risk for pulmonary embolism. The filters are catch blood clots before they travel to the lungs.
Problems With The IVC Filters
An IVC Filter study published in JAMA Internal Medicine stated that less than 10 percent of the filters studied were successfully removed from patients and eight percent of the recipients of the IVC filters suffered a pulmonary embolism despite the presence of the IVC filter.
The FDA in 2014 has encouraged doctors to remove IVC filters within one to two months after the risk of pulmonary embolism has passed.
IVC Filter Lawsuits For:
Fracture of the IVC Filer
Movement of the filter out of place
Filter Puncturing the vena cava
Patients and doctors were not adequately warned about their potential for defect.
The MDL is requested for the Northern District of Texas or Nevada.